Ligand to Report Third Quarter 2018 Results on November 8th
Go back to Ligand to Report Third Quarter 2018 Results on November 8th| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 287.38 -3.33 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $290.71 | 52 Week High | $139.79 | |||
| Open | $289.11 | 52 Week Low | $82.07 | |||
| Day High | $293.37 | P/E | 668.33 | |||
| Day Low | $284.87 | EPS | $0.43 | |||
| Volume | 107,782 | |||||

